Expression of ABCA1 in vascular endothelial cells and its significance in the pathogenesis of atherosclerosis

Abstract

Abstract: Objective To investigate the changes in the expressions of ATP-binding cassette transporter A1 (ABCA1), intercellular cell adhesion molecule type 1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) at mRNA and protein levels after the treatment of the vascular endothelial ECV304 cells with oxidized low-density lipoprotein (Ox-LDL) and 8-Br-cAMP, thereby to explore possible mechanisms by which ABCA1 affects the formation of atherosclerosis (AS). Methods Resuscitated and cultured ECV304 cells were incubated in serum-free medium for 12 h to induce the quiescence phase of growth, which were subsequently treated with Ox-LDL (30 ng/ml) and 8-Br-cAMP (0.5 mmol/L) respectively for 3, 6, 12, and 24 h. After the cells were harvested at the specified time points, the mRNA and protein levels of ABCA1, ICAM-1 and MCP-1 were detected by RT-PCR and Western blotting, respectively. Results The mRNA and protein expression levels of ABCA1, ICAM-1 and MCP-1 all increased after treatments with Ox-LDL and 8-Br-cAMP. The highest expression of ICAM-1 occurred in cells with a 12-hour treatment, and those of ABCA1 and MCP-1 occurred following 6-hour incubation with Ox-LDL. The expression peaks of ABCA1, ICAM-1 and MCP-1 all took place after 6-hour incubation with 8-Br-cAMP. Conclusions The mRNA and protein expressions of ICAM-1 and MCP-1 in vascular endothelial ECV304 cells increase in response to Ox-LDL treatment, in the event of which ABCA1 is also up-regulated to offer protective effects against AS. cAMP not only enhances the expression of ABCA1 but also those of ICAM-1 and MCP-1.

CLC Number:

LI Jian-hua, GUO Zhi-gang, WU Ping-sheng, YANG Yong-hong, LAI Wen-yan. Expression of ABCA1 in vascular endothelial cells and its significance in the pathogenesis of atherosclerosis[J]. Journal of Southern Medical University, 2004, 24(09): 980-983.

References

[1] Oram JF. ATP-binding cassette transporter A1 and cholesterol trafficking[J]. Curr Opin Lipidol, 2002, 13(4): 373-81.
[2] Wilcox JN, Couse TL, Wade DP, et al. Localization of human ATPbinding cassette transporter 1 (ABC1) in normal and atherosclerotic tissues[J]. Arterioscler Thromb Vasc Biol, 2001,21(3): 378-85.
[3] Panousis CG, Zuckerman SH. Interferon-γinduces downregulation of Tangier disease gene (ATP-binding-cassette transporter1) in macrophage derived foam cells[J]. Arterioscler Thromb Vasc Biol,2000, 20(6):1565-73.
[4] Simon BC, Noll B, Maisch B. Endothelial dysfunction-assessment of current status and approaches to therapy[J]. Herz, 1999, 24(1): 62-9.
[5] Reape TJ, Groot PH. Chemokines and atherosclerosis[J]. Atherosclerosis, 1999, 147(2): 213-25.
[6] Braun M, Pietsch P, Schror K, et al. Cellular adhesion molecules on vascular smooth muscle cells[J]. Cardiovasc Res, 1999, 41 (2): 395-408.
[7] Richard W, Clair ST. Pathogenesis of atherosclerosis[J]. Cardiol Rev, 1997, 6(1):14-24.
[8] Weber C, Erl W, Weber KS, et al. Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions[J]. Clin Chem Lab Med, 1999, 37(3): 243-9.
[9] Cushing SD, Berliner JA, Valente AJ, et al. Minimal modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells[J]. Proc Natl Sci USA, 1990, 87(13): 5134-8.
[10] Simon BC, Noll B, Maisch B. Endothelial dysfunction-assessment of current status and approaches to therapy[J]. Herz, 1999, 24(1): 62-75.
[11] Oram JF, Lawn RM, Garvin MR, et al. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages[J]. J Biol Chem, 2000, 275(44): 34508-22.
[12] Zhou X, Engel T, Goepfert C, et al. The ATP binding cassette transporter A1 contributes to the secretion of interleukin-1 beta from macrophages but not from monocytes[J]. Biochem Biophys Res Commun, 2002, 291(30): 598-604.